Maravai LifeSciences Holdings, Inc.

US$7.52As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:MRVIHealthcare
Country USA
PE (Fwd) •••
TSR 6Y CAGR (19.93%)
Div yield —
ROE (29.80%)
Biotechnology
Beta (5Y) 0.63
PE TTM —
TSR TTM 139.49%
Mkt cap US$1.955B
ROIC (10.34%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$7.70
2.45%
273.15%
Hold 4|8|4|11|0
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.12
0.12
0.13
0.13
13.13%
13.69%
24.61%
10.53%
Revenue$M
152.0
157.6
153.2
160.1
11.90%
12.62%
4.42%
7.84%
Peers (US$1.955B)
Cap (US$)
PE
1.944B
10.95x
Capital
TTM
5Y
10Y
Leveragex
0.513
(0.023)
(0.021)
EBIT/Intx
2.457
0.123
0.134
Own earn%
(119.73)
35.87
39.29
Sh yield%
40.09
30.39
30.25
Owners
Insiders/Inst%
0.14
52.81
Short interest%
3.60
SBC / revenue%
4.30
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
20
Op margin range%
0–5
$1 testx
—
Incr. ROIC%
5